The Danazol Capsules, cataloged under National Stock Number 6505-01-070-1634, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 3 manufacturers, enabling identification through both NSN and commercial part number lookups. 3 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-070-1634 |
| Primary Part Number | NDC00555-0635-02 |
| Item Name | Danazol Capsules |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Capsule Primary Container Content Quantity | 100.000 |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 200.000 MILLIGRAMS DANAZOL ACTIVE INGREDIENT |
| Capsule Type | HARD |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| D226 | Sanofi-Synthelabo, Inc (USA) |
| NDC00024-0305-06 | Sterling-Winthrop Research Institute a Div of Sterling Drug Inc (USA) |
| NDC00555-0635-02 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
NSN 6505-01-070-1634 is a Danazol Capsules, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-070-1634 has 3 cross-referenced part numbers: D226 (Sanofi-Synthelabo, Inc), NDC00024-0305-06 (Sterling-Winthrop Research Institute a Div of Sterling Drug Inc), NDC00555-0635-02 (Teva Pharmaceuticals Usa, Inc.).
There are 3 known substitutes for 6505-01-070-1634: 5940-00-636-7098, 6105-00-895-1020, 1670-01-547-6915. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00555-0635-02: Capsule Primary Container Content Quantity: 100.000; Part Name Assigned by Controlling Agency: DANAZOL CAPSULES USP 200MG 100S BT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 6 total characteristics are documented in the Federal Logistics Information System.